Full Text View
Tabular View
No Study Results Posted
Related Studies
Therapeutic Effect of Sildenafil in Patients With Coronary Vasospasm
This study has suspended participant recruitment.
( Patient study insurance expired )
Study NCT00454714   Information provided by Robert Bosch Gesellschaft für Medizinische Forschung mbH

First Received on March 29, 2007.   Last Updated on July 20, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Coronary Vasospasm
More general conditions related to this trial
Cardiovascular Diseases
Coronary Disease
Heart Diseases
Myocardial Ischemia
Vascular Diseases
Interventions listed in this trial
single dose Sildenafil
Single dose placebo
Additional drug interventions recognized in this trial
Sildenafil
More general drug interventions related to this trial
Cardiovascular Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Phosphodiesterase 5 Inhibitors
Phosphodiesterase Inhibitors
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Robert Bosch Gesellschaft für Medizinische Forschung mbH


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services